Demand for DrugDev Spark Soars among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Demand for DrugDev Spark Soars among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Experience DrugDev Spark solutions for site selection and activation, eConsent, site payments, and site engagement at complimentary “Clinical Coffee” live events
PHILADELPHIA PA and LONDON UK – DrugDev, a QuintilesIMS company, continues to strengthen its position as the clinical technology provider for small to mid-size biotechs and pharma worldwide with continued adoption of the DrugDev Spark™ unified clinical trial suite.
Sponsors unfamiliar with DrugDev Spark can experience solutions for site selection and activation, eConsent, site payments and site engagement with hands-on technology demonstrations and best practice discussions at a series of educational “Clinical Coffee” events. Register here to attend the live session, scheduled for September 27 from 9am-12pm ET in Parssipany, New Jersey.
DrugDev’s growth has come as a result of proven success improving clinical trials across therapeutic areas with sponsors of all sizes, including Actelion Pharmaceuticals, Alnylam Pharmaceuticals, Frenova Renal Research, Forty Seven, Inseption Group, Morphotek, Transition Therapeutics, Sanford Health and Sequiris in addition to Top 20 global pharmaceutical clients.
Watch a rare disease webinar with Alnylam and AMO Pharma discussing how to use technology to design and conduct more efficient and effective clinical research.
“Clinical innovation isn’t reserved exclusively for Top 20 Pharma trying to build their brand as a sponsor of choice,” said DrugDev Chief Marketing Officer Brett Kleger. “Increasingly, smaller pharmas and biotechs are adopting DrugDev Spark to improve site relationships and productivity, elevate their CRO, and support internal study teams with efficient automation tools. Scalable technology like ours is flexible enough for any budget, and levels the playing field for smaller sponsors and biotechs worldwide.”
To learn how DrugDev Spark is changing the game for smaller pharmaceutical companies, begin a conversation or request a demo at www.drugdev.com.
About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.